Mesalamine Kit
Product Images NDC 45802-923

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 45802-923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Image (Image 01)

Structural Formula Image (Image 01)
Chemical structure of mesalamine, showing a benzene ring with amino (NH2), hydroxyl (OH), and carboxyl (COOH) functional groups attached at specific positions on the ring.*
FDA Label Image

Remove The Bottles Image (Image 02)

Remove The Bottles Image (Image 02)
An instructional illustration showing how to open a sealed pouch. It depicts hands holding the pouch with instructions to grasp the seam and tear down after cutting the seal with scissors, demonstrating the correct opening method.*
FDA Label Image

Prepare The Medication For Administration Image (Image 03)

Prepare The Medication For Administration Image (Image 03)
An instructional illustration showing two hands handling a medical applicator device, likely part of the Mesalamine kit by Padagis Israel Pharmaceuticals Ltd. The left hand holds a cylindrical tube, and the right hand holds a nozzle or applicator tip, demonstrating preparation or assembly steps.*
FDA Label Image

Assume The Correct Body Position Image #1 (Image 04)

Assume The Correct Body Position Image #1 (Image 04)
An anatomical illustration showing the lower torso and legs of an adult human body lying on their side, with one leg bent at the knee and the other extended straight. This diagram is commonly used to depict a side-lying position for medical or pharmaceutical instructions.*
FDA Label Image

Assume The Correct Body Position Image #2 (Image 05)

Assume The Correct Body Position Image #2 (Image 05)
An illustration showing a person in a kneeling and leaning forward yoga-like pose, resting on their knees and forearms with the head down. The image depicts a specific body posture but contains no visible text or product-related information.*
FDA Label Image

Administer The Medication Image (Image 06)

Administer The Medication Image (Image 06)
A black-and-white line drawing illustration showing a hand holding and preparing a nasal spray or drop device, with a finger positioned on the nozzle and the other hand steadying the bottle. The image appears to demonstrate how to use the delivery device included in the medication kit for Mesalamine.*
FDA Label Image

Image 07

Image 07
Packaging label panel for Mesalamine prescription drug kit by Padagis Israel Pharmaceuticals Ltd. It includes placeholders for the product's serial number, lot number, and expiration date.*
FDA Label Image

Image 08

Image 08
Mesalamine Rectal Suspension, USP Enema 4g/60 mL unit-dose kit packaging label. The box contains 7 x 60 mL unit-dose bottles. The labeler is Padagis Israel Pharmaceuticals Ltd, and the product is for rectal use only with instructions to shake well before using. It includes a barcode and dosing information warning the product may stain surfaces and should be stored between 20-25°C.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.